Radiation-induced EGFR-signaling and control of DNA-damage repair.
about
Guidelines for the use and interpretation of assays for monitoring autophagyEGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatmentRadioresistance of Brain TumorsMechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate CancerTherapeutic Implications for Overcoming Radiation Resistance in Cancer TherapyClinical application of genetics to guide prevention and treatment of oral diseasesCaveolin-1: an essential modulator of cancer cell radio-and chemoresistanceFound in translation: Integrating laboratory and clinical oncology researchAfatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage.Rheumatoid arthritis is associated with rs17337023 polymorphism and increased serum level of the EGFR proteinCetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancerEpidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistanceSynthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cellsMET Inhibition Results in DNA Breaks and Synergistically Sensitizes Tumor Cells to DNA-Damaging Agents Potentially by Breaching a Damage-Induced Checkpoint ArrestPolymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy.Erlotinib-cisplatin combination inhibits growth and angiogenesis through c-MYC and HIF-1α in EGFR-mutated lung cancer in vitro and in vivo.Formononetin inhibits enterovirus 71 replication by regulating COX- 2/PGE₂ expressionThe cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells.Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation.Biological response of cancer cells to radiation treatment.Afatinib increases sensitivity to radiation in non-small cell lung cancer cells with acquired EGFR T790M mutation.Role of IGF-1 receptor in radiation response.Identification of an AAA ATPase VPS4B-dependent pathway that modulates epidermal growth factor receptor abundance and signaling during hypoxia.Japanese encephalitis virus induces matrix metalloproteinase-9 expression via a ROS/c-Src/PDGFR/PI3K/Akt/MAPKs-dependent AP-1 pathway in rat brain astrocytesRNA interference for epidermal growth factor receptor enhances the radiosensitivity of esophageal squamous cell carcinoma cell line Eca109Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776.Epidermal growth factor regulates hematopoietic regeneration after radiation injuryPredictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer models.Dasatinib Inhibits DNA Repair after Radiotherapy Specifically in pSFK-Expressing Tumor Areas in Head and Neck Xenograft Tumors.Receptor signaling as a regulatory mechanism of DNA repair.Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma.Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches.Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinoma.Emerging biological treatments for uterine cervical carcinoma.Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy.Nuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors.Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: differences between antibodies and TK inhibitors.Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function.
P2860
Q21996341-CE002361-7DA5-479D-987C-2DE21B85F996Q24338426-D8ECFF6B-6320-4FA4-864E-F183B50E8303Q26752579-60017102-7C93-4E50-8F7A-6A7786A8CCC6Q26766638-A049D6C8-FA44-4127-BE1B-7BD18CBE70B8Q26777016-AF421175-DAEA-4079-9320-FE0C66088BA4Q26999507-F43D9D73-AE42-476F-A07D-3F0856114FE1Q28392375-17D04BD2-EE73-4132-815C-3D45640941A0Q28744471-8E82042A-53F9-4943-9F65-B52812E848B1Q33591405-34D32C0C-7B5D-47CD-83E9-BFA43F932B9BQ33670896-86B6F395-DC4F-41CC-B476-8CA0AA920FCAQ33898265-6039F9B8-0F89-4637-B5AF-E99F517228F3Q34017668-3C8DA3D0-C5CA-45EB-97A3-6785FA042BD7Q34105339-4C24D334-118B-4F7A-9F95-83D4525C75F1Q34447273-0D1C76C4-CA15-4A1B-B203-04259230184CQ34972637-E158ECBE-EE29-4177-B5F0-B89B6A23ED29Q35007346-6DBD9BC4-4FE5-4550-88E4-0874E2A36EACQ35152542-9364D6BC-4420-4233-A60A-17AF7030936BQ35153758-51AA4915-47D3-497F-A33C-9E6C2AEAEB35Q35247181-9E01B67B-45C1-4CE9-A53D-F4441DA414EEQ35558949-0846102B-E264-4D57-B154-5614F3C1A20BQ35600132-69B47B6B-3B53-4856-9838-F95D0B93CBFBQ35742415-F8239C2D-5433-47CB-9734-4E1974A1EE92Q35762239-E9F4B459-33AB-4418-B8DF-6827EF39B0D9Q35806672-9728FBFA-EACC-4467-B22F-9CA37D60BEEFQ35818409-7ACB9C20-F1BA-4EA1-9B45-E44A9023A9F8Q35944593-06FCBCFA-85B6-4D69-9FDE-10156214FBC0Q36214686-E17C38E1-0451-476B-B044-4E6EAF9D8D39Q36225686-CC6D10C0-13E1-4D03-9EB8-AF80AE6FCFE2Q36674536-1DDC4651-4C0A-431D-BFA9-4E3F6CA811E6Q36770297-828F7726-B042-439B-850A-89D76E5571D8Q37060946-F5D7441E-89F8-4749-AEA8-0D742D81BFA7Q37368256-1857DF5E-121B-41D8-8926-CB536A9BAE56Q37414399-28E1FF4D-2A94-4175-949F-85CC38DFCA0BQ37489947-FD3105F0-C5AB-45B5-BE5B-ACD9A0F34321Q37515219-DFCAC685-D47F-4CE5-886A-224E3695C121Q37540968-44E2A8F0-1B4F-48D5-B135-B89540AA13D2Q37584899-24828ED2-882E-48BD-B98E-8E9DC3213DD6Q37622619-905A8AD4-95C7-402A-A87D-50A775AF22F3Q37628728-DBABE815-AE40-4A94-A1FA-B31608F47FF3Q37676970-9C49EAA1-9233-41E7-842F-2E7EB0AF1379
P2860
Radiation-induced EGFR-signaling and control of DNA-damage repair.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Radiation-induced EGFR-signaling and control of DNA-damage repair.
@en
Radiation-induced EGFR-signaling and control of DNA-damage repair.
@nl
type
label
Radiation-induced EGFR-signaling and control of DNA-damage repair.
@en
Radiation-induced EGFR-signaling and control of DNA-damage repair.
@nl
prefLabel
Radiation-induced EGFR-signaling and control of DNA-damage repair.
@en
Radiation-induced EGFR-signaling and control of DNA-damage repair.
@nl
P2093
P2860
P1476
Radiation-induced EGFR-signaling and control of DNA-damage repair.
@en
P2093
H Peter Rodemann
Klaus Dittmann
Mahmoud Toulany
P2860
P304
P356
10.1080/09553000701769970
P577
2007-11-01T00:00:00Z